In the past decade, several gene therapies for non-oncologic diseases1 and bladder cancer2 have received regulatory approval. Such approaches hold substantial potential for intractable neurological diseases such as high-grade glioma, including glioblastoma—a fatal brain cancer without an effective treatment.